While BAF alterations occur across diverse malignancies and typically in older patients, ATRT in infants and young children is most often driven by biallelic SMARCB1 loss—contrasting with the monoallelic tumor-suppressor patterns common in other cancers [29]. The gene discussed is SMARCB1; the disease is cancer.